Overview
Roshan Asrani is a Hematologist in New York, New York. Dr. Asrani has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. His top areas of expertise are Hodgkin Lymphoma, Chronic T-Cell Leukemia (CTCL), Large-Cell Immunoblastic Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL).
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1470 Madison Ave, New York, NY 10029
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist in New York, New York. Dr. Horwitz is rated as an Elite provider by MediFind in the treatment of Midline Lethal Granuloma. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
Atlantic Medical Group Hematology Oncology
Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as a Distinguished provider by MediFind in the treatment of Midline Lethal Granuloma. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.
Memorial Sloan Kettering Cancer Center
Jasmine Zain is a Hematologist and an Oncologist in New York, New York. Dr. Zain is rated as an Elite provider by MediFind in the treatment of Midline Lethal Granuloma. Her top areas of expertise are T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Zain is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Burkitt LymphomaDr. Asrani isAdvanced. Learn about Burkitt Lymphoma.
- Chronic T-Cell Leukemia (CTCL)Dr. Asrani isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Classical Hodgkin LymphomaDr. Asrani isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Hodgkin LymphomaDr. Asrani isAdvanced. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Asrani isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Asrani isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Asrani isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Asrani isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Asrani isExperienced. Learn about Agranulocytosis.
